Digital twins, once considered a complex and experimental concept in preventative health, are rapidly becoming viable thanks to advances in artificial intelligence and new data on genomics, patient outcomes, and drug effectiveness. These technological strides are bringing the vision of personalized health simulations closer than ever before, offering potential breakthroughs for early intervention and tailored treatments.
The American College of Physicians argues that referring to healthcare professionals as 'providers' reduces the patient-physician relationship to a mere business transaction, which undermines the essential trust and care involved.
This year, health care is expected to be a major topic of discussion among lawmakers. However, despite the debates, significant legislative progress on health care reform is unlikely due to political challenges ahead of the midterm elections.
The FDA has selected a former senior executive from a health AI company to lead its digital health center, signaling a strategic move to integrate advanced technology expertise within its operations.
Facing declining profits and rising expenses, leading health insurers are rapidly integrating AI technologies across their extensive operations to improve efficiency and reduce costs.
Sanofi is undergoing a leadership change with Paul Hudson stepping down as CEO. The pharmaceutical giant is now facing questions about which drugs will fuel its future growth.
Several European venture capital firms have joined forces with the goal of enhancing the funding environment for biotech startups across the region.
Working as a therapist often feels isolating, but AI technologies are transforming this experience. AI tools provide valuable support, helping clinicians gain insights, streamline patient care, and improve therapeutic outcomes. By integrating AI, I find myself more connected and effective in addressing my patients' needs.
When patients face the same out-of-pocket cost regardless of the healthcare option they select, they lack motivation to choose wisely. Introducing financial incentives for making cost-effective health decisions can encourage more responsible healthcare consumption and potentially reduce overall expenses.
With the surge in consumers accessing lab tests and genetic screenings directly, experts warn of potential repercussions in sectors like insurance underwriting, loan approvals, and employment evaluations.